{"OMIM ID": "OMIM:254770", "DISEASE": "Epilepsy, Myoclonic Juvenile", "RECORD": "Rare disease patients have complex clinical representations. Patients with Epilepsy, Myoclonic Juvenile present clinical features that include seizures, movement disorders, cognitive impairment, and psychiatric symptoms. The diagnosis of Epilepsy, Myoclonic Juvenile is based on clinical features, genetic testing, and brain imaging. The treatment of Epilepsy, Myoclonic Juvenile is symptomatic and may include antiepileptic drugs, steroids,. Some special cases also present surgical treatment.\n\nEpilepsy, Myoclonic Juvenile: Broader Related Topics\n\nEpilepsy\n\nMyoclonic\n\nJuvenile\n\nEpilepsy, Myoclonic Juvenile: Rare Disease Types\n\nEpilepsy, Myoclonic Juvenile: Orphanet\n\nEpilepsy, Myoclonic Juvenile: Rare Disease Status\n\nEpilepsy, Myoclonic Juvenile: Drug Target\n\nEpilepsy, Myoclonic Juvenile: Dosing\n\nEpilepsy, Myoclonic Juvenile: Brand Names\n\nEpilepsy, My. The main symptomatic differences of Epilepsy, Myoclonic Juvenile from similar diseases is that Epilepsy, Myoclonic Juvenile: In children, the most common age of onset is 2 to 4 years. Epilepsy, Myoclonic Juvenile: Symptoms may include seizures, movement disorders, cognitive impairment, and psychiatric symptoms. Epilepsy, Myoclonic Juvenile: The diagnosis of Ep", "SUMMARY": "ilepsy, Myoclonic Juvenile is based on clinical features, genetic testing, and brain imaging. Epilepsy, Myoclonic Juvenile: The treatment of Epilepsy, Myoclonic Juvenile is symptomatic and may include ant"}